On Thursday, Merrimack Pharmaceuticals Inc (NASDAQ:MACK)’s shares dwindled -2.44%, and closed at $12.00, as Merrimack Pharmaceuticals, declared that it will present preclinical and clinical data showcasing its deep oncology pipeline at the 2015 American Association for Cancer Research Annual Meeting being held April 18-22, 2015 at the Pennsylvania Convention Center in Philadelphia. The presentations describe recent data from Merrimack’s proprietary antibody engineering and nanoliposomal technology platforms, in addition to oral presentations on Phase 1 clinical trials of MM-302 and MM-141.
Data will be presented in two oral sessions and three poster sessions.
Oral Presentations
Session Title: Clinical Trials of New Drugs in Breast Cancer
A Phase 1 study of MM-302, a HER2-targeted PEGylated liposomal doxorubicin, in patients with HER2+ metastatic breast cancer.
Monday, April 20, 2015, 10:30 AM ET
Room 103, Pennsylvania Convention Center
Poster Sessions
Session Title: Growth Factor Receptors and Other Surface Antigens as Targets for Therapy
Mechanistic characterization of MM-131, a bispecific antibody that blocks c-Met signaling through concurrent targeting of EpCAM.
Monday, April 20, 2015, 8:00 AM - 12:00 PM ET
Section 29
Merrimack Pharmaceuticals, Inc., a biopharmaceutical corporation, engages in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States.
Pandora Media Inc (NYSE:P), declined -2.38%, and closed at $16.83, during the last trading session on Thursday, as Pandora, is partnering with AEG Live’s Concerts West and the Rolling Stones to offer listeners an exclusive ticket pre-sale for the upcoming ZIP CODE tour. The presale begins on Thursday, April 9 at 10am in all US time zones, four full days before the general sale on April 13.
Pandora Media, Inc. provides Internet radio services in the United States. The corporation allows listeners to create up to 100 personalized stations to access free music and comedy catalogs, in addition to offers Pandora One, a paid subscription service to listeners.
At the end of Thursday’s trade, Realty Revenue Corp (NYSE:O), dipped -2.37%, and closed at $49.36, as Realty Revenue Corporation, The Monthly Dividend Corporation®, declared Neil Abraham has joined the corporation as Senior Vice President, Investments. Mr. Abraham will report to the corporation’s Chief Operating Officer and Chief Investment Officer, Sumit Roy, and will focus primarily on the corporation’s investment activities.
Realty Revenue Corporation is a publicly traded real estate investment trust. It invests in the real estate markets of the United States. The firm makes investments in commercial real estate. Realty Revenue Corporation was founded in 1969 and is based in Escondido, California.
Vornado Realty Trust (NYSE:VNO), ended its Thursday’s trading session with -2.37% loss, and closed at $107.14, as on April 6, 2015,the VORNADO REALTY TRUS, declared that it has accomplished a $308 million refinancing of RiverHouse Apartments, a three building, 1,670 unit complex located in Washington, D.C. The loan is interest-only at LIBOR + 1.28% and matures in 2025. The Corporation realized net proceeds of about $43 million.
The property was formerly encumbered by a 5.43% $195 million mortgage maturing in April 2015 and a $64 million mortgage at LIBOR +1.53% maturing in 2018.
Vornado Realty Trust is a publicly owned real estate investment trust. The firm invests in the real estate markets of the United States. It makes investments in commercial real estate properties to create its portfolio.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
